The University of Chicago Header Logo

Connection

Rudolph Navari to Clinical Trials, Phase I as Topic

Back to Details
This is a "connection" page, showing publications Rudolph Navari has written about Clinical Trials, Phase I as Topic.
Rudolph Navari
Connection Strength
0.084
Clinical Trials, Phase I as Topic
  1. Palonosetron for the prevention of chemotherapy-induced nausea and vomiting in patients with cancer. Future Oncol. 2010 Jul; 6(7):1073-84.
    View in: PubMed
    Score: 0.084
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.